These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 328464)
41. The clinical pharmacology of antiarrhythmic drugs. Part II: Quinidine, propranolol, diphenylhydantoin, and bretylium. Levitt B; Borer JS; Sarapa A Cardiovasc Nurs; 1974; 10(6):27-31. PubMed ID: 4498549 [No Abstract] [Full Text] [Related]
42. Control of myocardial oxygen consumption: physiologic and clinical considerations. Braunwald E Am J Cardiol; 1971 Apr; 27(4):416-32. PubMed ID: 4396726 [No Abstract] [Full Text] [Related]
43. Pharmacology and pharmacokinetics of drugs used to treat cardiac disease in horses. Muir WW; McGuirk SM Vet Clin North Am Equine Pract; 1985 Aug; 1(2):335-52. PubMed ID: 3878193 [TBL] [Abstract][Full Text] [Related]
44. [Mechanisms and clinical profile of inotropic action of medicines for heart failure]. Yazaki Y Kokyu To Junkan; 1989 Dec; 37(12):1271-7. PubMed ID: 2694254 [No Abstract] [Full Text] [Related]
45. How useful are serum levels of cardiac drugs? Pennock RS Am Fam Physician; 1978 Apr; 17(4):194-6. PubMed ID: 645538 [No Abstract] [Full Text] [Related]
46. Digitalis toxicity: drug interactions promoting toxicity and the management of toxicity. Bigger JT; Strauss HC Semin Drug Treat; 1972; 2(2):147-77. PubMed ID: 4404460 [No Abstract] [Full Text] [Related]
47. [Cellular bases of the positive inotropic effect of cardiac glycosides, catecholamines and methylxanthines]. Krebs R Hippokrates; 1970 Sep; 41(3):354-65. PubMed ID: 5473616 [No Abstract] [Full Text] [Related]
48. A qualitative distinction between the beta-receptor-blocking and local anesthetic actions of antiarrhythmic agents. Shinebourne E; White R; Hamer J Circ Res; 1969 Jun; 24(6):835-41. PubMed ID: 5786789 [No Abstract] [Full Text] [Related]
49. [Cellular mechanisms of the etiology of cardiac rhythm disturbances and of the action of basic anti-arrhythmia drugs]. Lewartowski B; Kwiatkowska B Kardiol Pol; 1970; 13(4):341-7. PubMed ID: 4924744 [No Abstract] [Full Text] [Related]
50. Protection from digitalis toxicity with the prophylactic use of diphenylhydantoin sodium. An arrhythmic-inotropic dissociation. Helfant RH; Scherlag BJ; Damato AN Circulation; 1967 Jul; 36(1):119-24. PubMed ID: 6027207 [No Abstract] [Full Text] [Related]
51. Hemodynamic and electrocardiographic effects of hyperpotassemia. Differences in response to slow and rapid increases in concentration of plasma K. Surawicz B; Chlebus H; Mazzoleni A Am Heart J; 1967 May; 73(5):647-64. PubMed ID: 6024862 [No Abstract] [Full Text] [Related]
52. Factors affecting pulsus alternans in the rapidly driven heart and papillary muscle. Badeer HS; Ryo UY; Gassner WF; Kass EJ; Cavaluzzi J; Gilbert JL; Brooks CM Am J Physiol; 1967 Nov; 213(5):1095-101. PubMed ID: 4964181 [No Abstract] [Full Text] [Related]
53. Digitalis versus diuretics: an individualized approach. Wood GL Vet Clin North Am; 1978 May; 8(2):245-56. PubMed ID: 685068 [No Abstract] [Full Text] [Related]
54. Drug action, reaction, and interaction. II. Iatrogenic cardiopathies. Aviado DM J Clin Pharmacol; 1975 Oct; 15(10):641-55. PubMed ID: 1184768 [No Abstract] [Full Text] [Related]
55. Actions of diphenylhydatoin on the electrical properties of isolated rabbit and canine atria. Strauss HC; Bigger JT; Bassett AL; Hoffman BF Circ Res; 1968 Sep; 23(3):463-77. PubMed ID: 5676455 [No Abstract] [Full Text] [Related]
56. Letter: Correction of heart failure with treatment of hyperglycemia. N Engl J Med; 1976 Mar; 294(12):669-70. PubMed ID: 1246263 [No Abstract] [Full Text] [Related]
57. The current status of diphenylhydantoin in heart disease. Mercer EN; Osborne JA Ann Intern Med; 1967 Nov; 67(5):1084-107. PubMed ID: 4860765 [No Abstract] [Full Text] [Related]
58. Letter: Cardiac effects of digitalis. McGrath H N Engl J Med; 1975 Aug; 293(9):457. PubMed ID: 1152962 [No Abstract] [Full Text] [Related]